Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know

Simply Wall StJul 13 00:57

SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024

SANTA CLARA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company

GlobeNewswireJun 6 04:09

6 of the Top 10 Medical Device Manufacturers Rely On AcuityMD's Commercial Intelligence Platform to Modernize Operations, Drive Revenue

AcuityMD now supports more than 200 MedTech companies, including leaders BD and SI-BONEBOSTON--(BUSINESS WIRE)--AcuityMD today announced its commercial intelligence platform for medical technology (Me

BusinesswireJun 4 22:00

Osteotec Announces Exclusive UK and Ireland Distribution Agreement With SI-BONE

NEWBURY, England, May 16, 2024 /PRNewswire/ -- Osteotec, the market-leading manufacturer and distributor of medical devices, is pleased to announce a new partnership with SI-BONE to exclusively distr

PR NewswireMay 16 23:00

Osteotec Announces Lisa Watts as National Sales Manager of New Spine Division

NEWBURY, England, May 15, 2024 /PRNewswire/ -- Osteotec, the market-leading manufacturer and distributor of medical devices, today announced it has strengthened its leadership team with the appointme

PR NewswireMay 15 23:00

SI-BONE, Inc.'s (NASDAQ:SIBN) Price In Tune With Revenues

With a price-to-sales (or "P/S") ratio of 4.5x SI-BONE, Inc. (NASDAQ:SIBN) may be sending bearish signals at the moment, given that almost half of all Medical Equipment companies in the United States

Simply Wall StMay 8 22:30